CD55 Antikörper (AA 301-381)
-
- Target Alle CD55 Antikörper anzeigen
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
Bindungsspezifität
- AA 301-381
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CD55 Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS), ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Kreuzreaktivität
- Human
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human CD55
- Isotyp
- IgG
- Top Product
- Discover our top product CD55 Primärantikörper
-
anti-Complement Decay-Accelerating Factor (CD55) (AA 35-134) antibody
CD55 Reaktivität: Human WB, ELISA, PLA Wirt: Maus Monoclonal 1G3 unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 35-285) antibodyCD55 Reaktivität: Human WB, ELISA, IHC (fro), ICC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 40-300) antibodyCD55 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 51-79) antibodyCD55 Reaktivität: Human WB, FACS, IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 35-134) antibodyCD55 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 1D7 unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (Center) antibodyCD55 Reaktivität: Human WB, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) antibodyCD55 Reaktivität: Human, Non-Human Primate WB, FACS, IP, IHC (p) Wirt: Maus Monoclonal MEM-118 unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 254-372) antibodyCD55 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) (AA 35-126) antibodyCD55 Reaktivität: Human IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Decay-Accelerating Factor (CD55) antibody (Biotin)CD55 Reaktivität: Human, Non-Human Primate WB, FACS, IP, IHC (p) Wirt: Maus Monoclonal MEM-118 Biotin
-
- Applikationshinweise
-
ELISA 1:500-1000
FCM 1:20-100
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- CD55 (Complement Decay-Accelerating Factor (CD55))
- Andere Bezeichnung
- CD55/DAF (CD55 Produkte)
- Synonyme
- CR antikoerper, CROM antikoerper, DAF antikoerper, TC antikoerper, Daf antikoerper, Daf-GPI antikoerper, Daf1 antikoerper, GPI-DAF antikoerper, CD55 molecule (Cromer blood group) antikoerper, CD55 molecule, decay accelerating factor for complement antikoerper, CD55 antikoerper, Cd55 antikoerper
- Hintergrund
-
Synonyms: CR, TC, DAF, CROM, Complement decay-accelerating factor, CD55
Background: This protein recognizes C4b and C3b fragments that condense with cell-surface hydroxyl or amino groups when nascent C4b and C3b are locally generated during C4 and c3 activation. Interaction of daf with cell-associated C4b and C3b polypeptides interferes with their ability to catalyze the conversion of C2 and factor B to enzymatically active C2a and Bb and thereby prevents the formation of C4b2a and C3bBb, the amplification convertases of the complement cascade.
- Gen-ID
- 1604
- UniProt
- P08174
- Pathways
- Komplementsystem, Regulation of Leukocyte Mediated Immunity
-
